-
Posted by Paula Wallace
- |
-
7 January, 2021
BIOTECHNOLOGY company Moderna pioneering messenger RNA (mRNA) therapeutics and vaccines, and Kuehne+Nagel have agreed an international supply chain arrangement to provide distribution and storage of the COVID-19 Vaccine Moderna.
This content is for members only
Create a free account with www.thedcn.com.au to access this exclusive content.
Already a member?Sign in
